ID   RNJ1_BACSU              Reviewed;         555 AA.
AC   Q45493;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-JUL-2015, entry version 103.
DE   RecName: Full=Ribonuclease J1 {ECO:0000255|HAMAP-Rule:MF_01491};
DE            Short=RNase J1 {ECO:0000255|HAMAP-Rule:MF_01491};
DE            EC=3.1.-.- {ECO:0000255|HAMAP-Rule:MF_01491};
GN   Name=rnjA {ECO:0000255|HAMAP-Rule:MF_01491}; Synonyms=ykqC;
GN   OrderedLocusNames=BSU14530;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=8969500;
RA   Winters P., Caldwell R.M., Enfield L., Ferrari E.;
RT   "The ampS-nprE (124 degrees-127 degrees) region of the Bacillus
RT   subtilis 168 chromosome: sequencing of a 27 kb segment and
RT   identification of several genes in the area.";
RL   Microbiology 142:3033-3037(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RA   Caldwell R.M., Ferrari E.;
RT   "Sequence analysis of the mobA-ampS region of the Bacillus subtilis
RT   chromosome.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [4]
RP   FUNCTION AS AN ENDONUCLEASE, COFACTOR, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=168;
RX   PubMed=15831787; DOI=10.1093/nar/gki505;
RA   Even S., Pellegrini O., Zig L., Labas V., Vinh J.,
RA   Brechemmier-Baey D., Putzer H.;
RT   "Ribonucleases J1 and J2: two novel endoribonucleases in B.subtilis
RT   with functional homology to E.coli RNase E.";
RL   Nucleic Acids Res. 33:2141-2152(2005).
RN   [5]
RP   SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=168;
RX   PubMed=17005971; DOI=10.1099/mic.0.29152-0;
RA   Hunt A., Rawlins J.P., Thomaides H.B., Errington J.;
RT   "Functional analysis of 11 putative essential genes in Bacillus
RT   subtilis.";
RL   Microbiology 152:2895-2907(2006).
RN   [6]
RP   FUNCTION AS AN EXONUCLEASE, ENZYME REGULATION, DISRUPTION PHENOTYPE,
RP   AND MUTAGENESIS OF HIS-76.
RX   PubMed=17512403; DOI=10.1016/j.cell.2007.02.051;
RA   Mathy N., Benard L., Pellegrini O., Daou R., Wen T., Condon C.;
RT   "5'-to-3' exoribonuclease activity in bacteria: role of RNase J1 in
RT   rRNA maturation and 5' stability of mRNA.";
RL   Cell 129:681-692(2007).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF HIS-76.
RC   STRAIN=168;
RX   PubMed=17229210; DOI=10.1111/j.1365-2958.2006.05499.x;
RA   Britton R.A., Wen T., Schaefer L., Pellegrini O., Uicker W.C.,
RA   Mathy N., Tobin C., Daou R., Szyk J., Condon C.;
RT   "Maturation of the 5' end of Bacillus subtilis 16S rRNA by the
RT   essential ribonuclease YkqC/RNase J1.";
RL   Mol. Microbiol. 63:127-138(2007).
RN   [8]
RP   FUNCTION IN PRE-SCRNA PROCESSING, AND DISRUPTION PHENOTYPE.
RX   PubMed=17576666; DOI=10.1093/nar/gkm460;
RA   Yao S., Blaustein J.B., Bechhofer D.H.;
RT   "Processing of Bacillus subtilis small cytoplasmic RNA: evidence for
RT   an additional endonuclease cleavage site.";
RL   Nucleic Acids Res. 35:4464-4473(2007).
RN   [9]
RP   FUNCTION IN MRNA DECAY, AND DISRUPTION PHENOTYPE.
RX   PubMed=18445592; DOI=10.1074/jbc.M801461200;
RA   Deikus G., Condon C., Bechhofer D.H.;
RT   "Role of Bacillus subtilis RNase J1 endonuclease and 5'-exonuclease
RT   activities in trp leader RNA turnover.";
RL   J. Biol. Chem. 283:17158-17167(2008).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18713320; DOI=10.1111/j.1365-2958.2008.06400.x;
RA   Mader U., Zig L., Kretschmer J., Homuth G., Putzer H.;
RT   "mRNA processing by RNases J1 and J2 affects Bacillus subtilis gene
RT   expression on a global scale.";
RL   Mol. Microbiol. 70:183-196(2008).
RN   [11]
RP   FUNCTION AS AN ENDONUCLEASE, DOMAIN, AND MUTAGENESIS OF ASP-45;
RP   78-ASP-HIS-79; ASN-337 AND SER-366.
RX   PubMed=18204464; DOI=10.1038/nsmb.1376;
RA   Li de la Sierra-Gallay I., Zig L., Jamalli A., Putzer H.;
RT   "Structural insights into the dual activity of RNase J.";
RL   Nat. Struct. Mol. Biol. 15:206-212(2008).
RN   [12]
RP   SUBUNIT.
RC   STRAIN=168;
RX   PubMed=19193632; DOI=10.1074/mcp.M800546-MCP200;
RA   Commichau F.M., Rothe F.M., Herzberg C., Wagner E., Hellwig D.,
RA   Lehnik-Habrink M., Hammer E., Volker U., Stulke J.;
RT   "Novel activities of glycolytic enzymes in Bacillus subtilis:
RT   interactions with essential proteins involved in mRNA processing.";
RL   Mol. Cell. Proteomics 8:1350-1360(2009).
RN   [13]
RP   FUNCTION IN 23S RRNA PROCESSING, RNASE ACTIVITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=19880604; DOI=10.1128/JB.01096-09;
RA   Redko Y., Condon C.;
RT   "Maturation of 23S rRNA in Bacillus subtilis in the absence of Mini-
RT   III.";
RL   J. Bacteriol. 192:356-359(2010).
RN   [14]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION WITH RNASE J2,
RP   AND SUBUNIT.
RC   STRAIN=168;
RX   PubMed=20025672; DOI=10.1111/j.1365-2958.2009.07004.x;
RA   Mathy N., Hebert A., Mervelet P., Benard L., Dorleans A.,
RA   Li de la Sierra-Gallay I., Noirot P., Putzer H., Condon C.;
RT   "Bacillus subtilis ribonucleases J1 and J2 form a complex with altered
RT   enzyme behaviour.";
RL   Mol. Microbiol. 75:489-498(2010).
RN   [15]
RP   INTERACTION WITH RNY, AND SUBUNIT.
RC   STRAIN=168;
RX   PubMed=21803996; DOI=10.1128/JB.05500-11;
RA   Lehnik-Habrink M., Newman J., Rothe F.M., Solovyova A.S.,
RA   Rodrigues C., Herzberg C., Commichau F.M., Lewis R.J., Stulke J.;
RT   "RNase Y in Bacillus subtilis: a natively disordered protein that is
RT   the functional equivalent of RNase E from Escherichia coli.";
RL   J. Bacteriol. 193:5431-5441(2011).
RN   [16]
RP   FUNCTION.
RX   PubMed=22014150; DOI=10.1111/j.1365-2958.2011.07888.x;
RA   Taverniti V., Forti F., Ghisotti D., Putzer H.;
RT   "Mycobacterium smegmatis RNase J is a 5'-3' exo-/endoribonuclease and
RT   both RNase J and RNase E are involved in ribosomal RNA maturation.";
RL   Mol. Microbiol. 82:1260-1276(2011).
RN   [17]
RP   FUNCTION, INTERACTION WITH RNASE J2, AND SUBUNIT.
RX   PubMed=21893286; DOI=10.1016/j.str.2011.06.018;
RA   Dorleans A., Li de la Sierra-Gallay I., Piton J., Zig L., Gilet L.,
RA   Putzer H., Condon C.;
RT   "Molecular basis for the recognition and cleavage of RNA by the
RT   bifunctional 5'-3' exo/endoribonuclease RNase J.";
RL   Structure 19:1252-1261(2011).
RN   [18]
RP   INTERACTION WITH PNP, AND SUBUNIT.
RC   STRAIN=168;
RX   PubMed=22198292; DOI=10.1016/j.jmb.2011.12.024;
RA   Newman J.A., Hewitt L., Rodrigues C., Solovyova A.S., Harwood C.R.,
RA   Lewis R.J.;
RT   "Dissection of the network of interactions that links RNA processing
RT   with glycolysis in the Bacillus subtilis degradosome.";
RL   J. Mol. Biol. 416:121-136(2012).
RN   [19]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=168;
RX   PubMed=22412379; DOI=10.1371/journal.pgen.1002520;
RA   Durand S., Gilet L., Bessieres P., Nicolas P., Condon C.;
RT   "Three essential ribonucleases-RNase Y, J1, and III-control the
RT   abundance of a majority of Bacillus subtilis mRNAs.";
RL   PLoS Genet. 8:E1002520-E1002520(2012).
RN   [20]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=168 / JH642, 168 / PY79, 168 / W168, and 168 trpC2;
RX   PubMed=23504012; DOI=10.1128/JB.00164-13;
RA   Figaro S., Durand S., Gilet L., Cayet N., Sachse M., Condon C.;
RT   "Bacillus subtilis mutants with knockouts of the genes encoding
RT   ribonucleases RNase Y and RNase J1 are viable, with major defects in
RT   cell morphology, sporulation, and competence.";
RL   J. Bacteriol. 195:2340-2348(2013).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN OPEN CONFORMATION, ACTIVE
RP   SITE, DISCUSSION OF MECHANISM, AND SUBUNIT.
RC   STRAIN=168;
RX   PubMed=21893285; DOI=10.1016/j.str.2011.06.017;
RA   Newman J.A., Hewitt L., Rodrigues C., Solovyova A., Harwood C.R.,
RA   Lewis R.J.;
RT   "Unusual, dual endo- and exonuclease activity in the degradosome
RT   explained by crystal structure analysis of RNase J1.";
RL   Structure 19:1241-1251(2011).
CC   -!- FUNCTION: An RNase that has endonuclease and 5'-3' exonuclease
CC       activity, playing a role in both rRNA and mRNA stability and
CC       degradation. Endonuclease activity can cleave within 4 nucleotides
CC       of the 5'-end of a triphosphorylated RNA. Endonuclease digestion
CC       by the RNase J1/J2 complex occurs at a different site and in some
CC       cases more efficiently than J1 or J2 alone. The exonuclease
CC       activity of the J1/J2 complex is highly processive on substrates
CC       longer than 5 nucleotides, on shorter substrates is distributive.
CC       Preferentially cleaves ssRNA, possibly in AU-rich regions. The 5'-
CC       exonuclease activity acts on 5'-hydroxyl and 5'-monophosphate but
CC       not 5'-triphosphate ends; it can digest through stem-loop
CC       structures if they are not too stable. Required for maturation of
CC       16S rRNA. Acts preferentially on 16S rRNA precursors after
CC       association of the 30S and 50S ribosomal subunits. Plays a role in
CC       the secondary pathway of 23S rRNA 5' end maturation. Probably also
CC       participates in processing of pre-scRNA (the precursor of the
CC       signal recognition particle RNA). {ECO:0000269|PubMed:15831787,
CC       ECO:0000269|PubMed:17229210, ECO:0000269|PubMed:17512403,
CC       ECO:0000269|PubMed:17576666, ECO:0000269|PubMed:18204464,
CC       ECO:0000269|PubMed:18445592, ECO:0000269|PubMed:18713320,
CC       ECO:0000269|PubMed:19880604, ECO:0000269|PubMed:20025672,
CC       ECO:0000269|PubMed:21893286, ECO:0000269|PubMed:22014150,
CC       ECO:0000269|PubMed:22412379, ECO:0000269|PubMed:23504012}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:15831787};
CC       Note=Binds 1 Ca(2+) cation per subunit. Seen in 1 crystal
CC       structure, it is not clear if it is physiologically important.
CC       {ECO:0000269|PubMed:15831787};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15831787};
CC       Note=Binds 2 Zn(2+) ions per subunit. It is not clear if Zn(2+) or
CC       Mg(2+) is physiologically important.
CC       {ECO:0000269|PubMed:15831787};
CC   -!- ENZYME REGULATION: 30S ribosomal subunit binding to Shine-Dalgarno
CC       sequences blocks exonuclease activity.
CC       {ECO:0000269|PubMed:17512403}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.47 uM for exonuclease on 30 nt RNA hybridized to 17 nt
CC         quenching DNA, J1 alone {ECO:0000269|PubMed:20025672};
CC         KM=0.22 uM for exonuclease on 30 nt RNA hybridized to 17 nt
CC         quenching DNA, J1/J2 complex {ECO:0000269|PubMed:20025672};
CC         Note=kcat is 0.58 sec (-1) for J1, 0.13 sec (-1) for J1/J2 and
CC         <0.005 sec (-1) for J2.;
CC   -!- SUBUNIT: Unclear whether it forms homodimers or belongs to a
CC       larger complex. According to (PubMed:20025672) probably does not
CC       form homodimers, while (PubMed:21893285) shows homodimer
CC       formation. Both reports show RNase J1 and J2 interaction, probably
CC       as a heterotetramer (PubMed:19193632) shows it is a component of a
CC       possible RNA degradosome complex composed of rny, rnjA, rnjB, pnp,
CC       pfkA and eno, while (PubMed:20025672) finds no evidence of an RNA
CC       degradosome complex. {ECO:0000269|PubMed:19193632,
CC       ECO:0000269|PubMed:20025672, ECO:0000269|PubMed:21803996,
CC       ECO:0000269|PubMed:21893285, ECO:0000269|PubMed:21893286,
CC       ECO:0000269|PubMed:22198292}.
CC   -!- INTERACTION:
CC       O31774:rny; NbExp=2; IntAct=EBI-6415229, EBI-6415578;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01491,
CC       ECO:0000269|PubMed:15831787, ECO:0000269|PubMed:17005971}.
CC       Note=Colocalizes with ribosomes.
CC   -!- DOMAIN: The C-terminal domain (residues 450-555) are required for
CC       nuclease activity and dimerization. {ECO:0000269|PubMed:18204464}.
CC   -!- DISRUPTION PHENOTYPE: Essential. In depletion experiments there is
CC       decreased 5'-exonuclease processing of 16S rRNA (PubMed:17512403),
CC       decreased accumulation of correctly-sized scRNA (PubMed:17576666),
CC       decreased decay of trp mRNA leader (PubMed:18445592), while
CC       correct processing of the 5' end of 23S rRNA no longer occurs in
CC       the absence of mrnC (PubMed:19880604). While depletion/deletion of
CC       RNase J1 or J2 has no large impact on global gene expression, a
CC       double mutant alters the expression of hundreds of genes
CC       (PubMed:18713320). In a more severe depletion experiment
CC       alteration of about 30% of transcripts was seen (PubMed:22412379).
CC       Later shown not to be essential in 4 strains, with a tripled
CC       doubling time. 168 trpC2 cells able to grow on minimal medium.
CC       Loss of competence for plasmid transformation, nearly complete
CC       loss of sporulation, poor growth at 30 degrees Celsius and no
CC       growth under 25 degrees Celsius. Increased sensitivity to a wide
CC       range of antibiotics. Irregularly shaped cells form clumps of
CC       spiral cells connected by long chains, with few visible septa,
CC       cell walls are altered with looser, less dense peptidoglycan.
CC       Double pnp-rnjA or rnjA-rny mutants could not be isolated
CC       (PubMed:23504012). {ECO:0000269|PubMed:17005971,
CC       ECO:0000269|PubMed:17229210, ECO:0000269|PubMed:17512403,
CC       ECO:0000269|PubMed:17576666, ECO:0000269|PubMed:18445592,
CC       ECO:0000269|PubMed:18713320, ECO:0000269|PubMed:19880604,
CC       ECO:0000269|PubMed:22412379, ECO:0000269|PubMed:23504012}.
CC   -!- MISCELLANEOUS: Present in about 2500 monomers per cell in mid-log
CC       phase.
CC   -!- SIMILARITY: Belongs to the metallo-beta-lactamase superfamily.
CC       RNA-metabolizing metallo-beta-lactamase-like family. Bacterial
CC       RNase J subfamily. {ECO:0000255|HAMAP-Rule:MF_01491}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF012285; AAC24928.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB13326.1; -; Genomic_DNA.
DR   PIR; B69862; B69862.
DR   RefSeq; NP_389336.1; NC_000964.3.
DR   RefSeq; WP_003245660.1; NZ_JNCM01000035.1.
DR   PDB; 3ZQ4; X-ray; 3.00 A; A/C/D/E=1-555.
DR   PDBsum; 3ZQ4; -.
DR   ProteinModelPortal; Q45493; -.
DR   SMR; Q45493; 5-554.
DR   DIP; DIP-46392N; -.
DR   IntAct; Q45493; 3.
DR   MINT; MINT-8365355; -.
DR   STRING; 224308.Bsubs1_010100008056; -.
DR   PaxDb; Q45493; -.
DR   EnsemblBacteria; CAB13326; CAB13326; BSU14530.
DR   GeneID; 939483; -.
DR   KEGG; bsu:BSU14530; -.
DR   PATRIC; 18974695; VBIBacSub10457_1539.
DR   GenoList; BSU14530; -.
DR   eggNOG; COG0595; -.
DR   HOGENOM; HOG000280201; -.
DR   InParanoid; Q45493; -.
DR   KO; K12574; -.
DR   OMA; PYHGEYR; -.
DR   OrthoDB; EOG6P5ZDC; -.
DR   PhylomeDB; Q45493; -.
DR   BioCyc; BSUB:BSU14530-MONOMER; -.
DR   EvolutionaryTrace; Q45493; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004534; F:5'-3' exoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0004521; F:endoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006397; P:mRNA processing; IDA:UniProtKB.
DR   GO; GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC.
DR   GO; GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC.
DR   GO; GO:0006364; P:rRNA processing; IDA:UniProtKB.
DR   Gene3D; 3.60.15.10; -; 1.
DR   HAMAP; MF_01491; RNase_J_bact; 1.
DR   InterPro; IPR001279; Beta-lactamas-like.
DR   InterPro; IPR011108; RMMBL.
DR   InterPro; IPR004613; RNase_J.
DR   InterPro; IPR030854; RNase_J_bac.
DR   InterPro; IPR001587; RNase_J_CS.
DR   PANTHER; PTHR11203:SF22; PTHR11203:SF22; 1.
DR   Pfam; PF00753; Lactamase_B; 1.
DR   Pfam; PF07521; RMMBL; 1.
DR   PIRSF; PIRSF004803; RnjA; 1.
DR   SMART; SM00849; Lactamase_B; 1.
DR   SUPFAM; SSF56281; SSF56281; 1.
DR   TIGRFAMs; TIGR00649; MG423; 1.
DR   PROSITE; PS01292; UPF0036; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Complete proteome; Cytoplasm; Endonuclease;
KW   Exonuclease; Hydrolase; Metal-binding; mRNA processing; Nuclease;
KW   Reference proteome; RNA-binding; rRNA processing; Zinc.
FT   CHAIN         1    555       Ribonuclease J1.
FT                                /FTId=PRO_0000215268.
FT   REGION      364    368       Substrate binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01491}.
FT   REGION      450    555       Required for endo- and 5'-exonuclease
FT                                activity and dimerization.
FT   ACT_SITE    195    195       Proton donor.
FT                                {ECO:0000305|PubMed:21893285}.
FT   ACT_SITE    368    368       Proton acceptor.
FT                                {ECO:0000305|PubMed:21893285}.
FT   METAL        49     49       Calcium; via carbonyl oxygen.
FT   METAL        51     51       Calcium.
FT   METAL        74     74       Zinc 1; via pros nitrogen; catalytic.
FT   METAL        76     76       Zinc 1; via pros nitrogen; catalytic.
FT   METAL        78     78       Zinc 2; catalytic.
FT   METAL        79     79       Zinc 2; via tele nitrogen; catalytic.
FT   METAL       142    142       Zinc 1; via tele nitrogen; catalytic.
FT   METAL       164    164       Zinc 1; catalytic.
FT   METAL       164    164       Zinc 2; catalytic.
FT   METAL       390    390       Zinc 2; via tele nitrogen; catalytic.
FT   METAL       443    443       Calcium.
FT   MUTAGEN      45     45       D->A: Slight decrease in endonuclease and
FT                                10-fold decrease in 5'-exonuclease
FT                                activity; when associated with A-337.
FT                                {ECO:0000269|PubMed:18204464}.
FT   MUTAGEN      76     76       H->A: Loss of endo- and 5'-exonuclease
FT                                activity. {ECO:0000269|PubMed:17229210,
FT                                ECO:0000269|PubMed:17512403}.
FT   MUTAGEN      78     79       DH->KA: Severe loss of endo- and 5'-
FT                                exonuclease activity.
FT                                {ECO:0000269|PubMed:18204464}.
FT   MUTAGEN     337    337       N->A: Slight decrease in endonuclease and
FT                                10-fold decrease in 5'-exonuclease
FT                                activity; when associated with A-45.
FT                                {ECO:0000269|PubMed:18204464}.
FT   MUTAGEN     366    366       S->L: 30% endonuclease and 10% 5'-
FT                                exonuclease activity.
FT                                {ECO:0000269|PubMed:18204464}.
FT   STRAND        8     21       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND       24     29       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND       32     38       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND       51     55       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX        58     61       {ECO:0000244|PDB:3ZQ4}.
FT   TURN         62     66       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND       67     73       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX        77     80       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX        83     87       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND       94     96       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX        98    111       {ECO:0000244|PDB:3ZQ4}.
FT   TURN        113    116       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      119    121       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      128    130       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      133    141       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      143    154       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      157    161       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      172    174       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       178    186       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      189    195       {ECO:0000244|PDB:3ZQ4}.
FT   TURN        197    200       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       208    221       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      226    229       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       235    246       {ECO:0000244|PDB:3ZQ4}.
FT   TURN        247    249       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      251    256       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       257    267       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       268    270       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       276    278       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       282    284       {ECO:0000244|PDB:3ZQ4}.
FT   TURN        285    287       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       290    292       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      293    297       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       307    312       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      326    329       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       338    350       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      354    356       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      358    361       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       371    380       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      383    391       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       393    405       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       410    412       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      421    425       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      428    431       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      439    443       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       452    464       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      466    473       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      475    477       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      480    492       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       494    497       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       500    516       {ECO:0000244|PDB:3ZQ4}.
FT   HELIX       523    542       {ECO:0000244|PDB:3ZQ4}.
FT   STRAND      547    554       {ECO:0000244|PDB:3ZQ4}.
SQ   SEQUENCE   555 AA;  61517 MW;  48091B448B8431C9 CRC64;
     MKFVKNDQTA VFALGGLGEI GKNTYAVQFQ DEIVLIDAGI KFPEDELLGI DYVIPDYTYL
     VKNEDKIKGL FITHGHEDHI GGIPYLLRQV NIPVYGGKLA IGLLRNKLEE HGLLRQTKLN
     IIGEDDIVKF RKTAVSFFRT THSIPDSYGI VVKTPPGNIV HTGDFKFDFT PVGEPANLTK
     MAEIGKEGVL CLLSDSTNSE NPEFTMSERR VGESIHDIFR KVDGRIIFAT FASNIHRLQQ
     VIEAAVQNGR KVAVFGRSME SAIEIGQTLG YINCPKNTFI EHNEINRMPA NKVTILCTGS
     QGEPMAALSR IANGTHRQIS INPGDTVVFS SSPIPGNTIS VSRTINQLYR AGAEVIHGPL
     NDIHTSGHGG QEEQKLMLRL IKPKFFMPIH GEYRMQKMHV KLATDCGIPE ENCFIMDNGE
     VLALKGDEAS VAGKIPSGSV YIDGSGIGDI GNIVLRDRRI LSEEGLVIVV VSIDMDDFKI
     SAGPDLISRG FVYMRESGDL INDAQELISN HLQKVMERKT TQWSEIKNEI TDTLAPFLYE
     KTKRRPMILP IIMEV
//
